Arm

• Medexus Pharmaceuticals Inc. experienced a significant stock price surge of 8.06% amid a spike in trading activity and increased market attention. • The company operates as a specialty pharmaceutical firm focusing on the commercialization and marketing of branded products for rare diseases and oncology support in Canada and the U.S. • Analysts advise investors to review recent regulatory filings and news releases to determine if the rally is driven by specific operational or financial changes.

• Leading brokerages have issued updated stock calls, upgrades, and target price revisions for several companies ahead of today's trading session. • Key companies on the radar include Bharat Forge, Gland Pharma, Zydus Life, Info Edge, Fractal Analytics, PNB, Afcons Infra, Vodafone, and Entero Health. • Analysts highlight growth drivers such as domestic business strength and generics exports, with specific projections including a 13% CAGR in loans and a 0.9% ROA by FY27 for certain entities.

As of 3pm Saturday, Australia had a total of 215 H5 bird flu cases nationally. Follow updatesGet our breaking news email, free app or daily news podcastThis is Adeshola Ore here to take you through today’s news as it unfolds.Let’s get into it. Continue reading...

• A source close to the Saudi army stated on August 7 that the coalition will not "stand idly by" in response to ongoing Houthi attacks in Yemen. • The United States has imposed sanctions on an unlicensed multi-state cryptocurrency exchange for allegedly processing millions of dollars for Iran's Islamic Revolutionary Guard Corps (IRGC). • In Israel, reports indicate the government revoked entry permits for U.S. Jews who volunteered with Palestinians, while former official Horowitz criticized the Prime Minister's Office for eroding judicial checks and balances.

Industry body calls for more regular reviews of repeat prescriptions to tackle ‘growing problem’The amount of wasted medicines thrown away in England in one year could fill 75 swimming pools, according to a pharmacy group.The National Pharmacy Association (NPA) estimated that 3,400 tonnes of partly used medicines were disposed of in England in 2024-25. Continue reading...

• Jan-Werner Müller argues that the Trump administration is subjugating scientific research to political imperatives, undermining U.S. soft power and technological progress. • Science adviser Michael Kratsios, who lacks a research background, proposes shifting decision-making power from university experts to private corporations. • This strategy relies on the premise that private firms, aided by AI, are better equipped to identify and pursue scientific breakthroughs than academic institutions.

• Readers are responding to an editorial warning that cuts to science funding will damage Britain's global standing and research capabilities. • A primary concern highlighted is the potential closure of the Jodrell Bank Observatory, a key site for astronomical research. • One contributor argues against the historical trend of prioritizing research based solely on near-term economic benefits and publication metrics.